The Role of the Autonomic Nervous System in the Pathophysiology of Obesity

Citations Over TimeTop 10% of 2017 papers

Abstract

Obesity is reaching epidemic proportions globally and represents a major cause of comorbidities, mostly related to cardiovascular disease. The autonomic nervous system (ANS) dysfunction has a two-way relationship with obesity. Indeed, alterations of the ANS might be involved in the pathogenesis of obesity, acting on different pathways. On the other hand, the excess weight induces ANS dysfunction, which may be involved in the haemodynamic and metabolic alterations that increase the cardiovascular risk of obese individuals, i.e., hypertension, insulin resistance and dyslipidemia. This article will review current evidence about the role of the ANS in short-term and long-term regulation of energy homeostasis. Furthermore, an increased sympathetic activity has been demonstrated in obese patients, particularly in the muscle vasculature and in the kidneys, possibily contributing to increased cardiovascular risk. Selective leptin resistance, obstructive sleep apnea syndrome, hyperinsulinemia and low ghrelin levels are possible mechanisms underlying sympathetic activation in obesity. Weight loss is able to reverse metabolic and autonomic alterations associated with obesity. Given the crucial role of autonomic dysfunction in the pathophysiology of obesity and its cardiovascular complications, vagal nerve modulation and sympathetic inhibition may serve as therapeutic targets in this condition.

Related Papers

• → Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension(1999)105 cited
• → Effect of experimental hyperinsulinemia on sympathetic nervous system activity in the rat(1988)53 cited
• Obesity, metabolism, and hypertension.(1990)
• → Evidence against the hypothesis that hyperinsulinemia increases sympathetic nervous system activity in man(1992)24 cited
• → Analysis of Human Autonomic Nervous Activity Based on Big Data Measurement via SmartPhone(2016)